Related Experiment Video
Updated: Jul 24, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Short-term holding room treatment of asthmatic children
Insights
Holding room treatment for childhood asthma is effective, with most children discharged within 24 hours. This approach is medically sound and significantly more cost-effective than hospitalization for pediatric asthma emergencies.
Area of Science:
- Pediatric Emergency Medicine
- Respiratory Medicine
- Health Economics
Background:
- Childhood status asthmaticus is a common pediatric emergency.
- Hospitalization is the traditional management approach, often involving prolonged intravenous therapy.
- Alternative, cost-effective treatment strategies are needed.
Purpose of the Study:
- To compare the efficacy and cost-effectiveness of holding room treatment versus hospitalization for pediatric status asthmaticus.
- To evaluate recurrence rates and treatment costs associated with each management strategy.
Main Methods:
- A randomized trial involving 51 patients treated in a holding room and 52 hospitalized patients.
- Data collection included length of stay, intravenous therapy duration, and 28-day recurrence rates.
- Cost analysis compared holding room treatment versus hospitalization.
Main Results:
- Two-thirds of patients in the holding room were discharged within 24 hours (mean 11.8 hours).
- No statistically significant difference in 28-day recurrence rates between holding room and hospitalized patients.
- Holding room treatment was significantly less expensive ($526 vs $1439) than hospitalization for patients receiving short-term intravenous therapy.
Conclusions:
- Holding room treatment is a medically effective alternative to hospitalization for selected children with status asthmaticus.
- This approach offers significant economic benefits, reducing healthcare costs.
- Holding room management represents an efficient and cost-effective strategy for pediatric asthma emergencies.
Abstract:
We undertook a randomized trial to compare holding room treatment vs hospitalization of patients with childhood status asthmaticus. Two thirds of 51 patients were discharged from a holding room within 24 hours (mean 11.8 +/- 4.61 hours); the others required hospitalization. One third of 52 hospitalized patients received less than or equal to 1 day of intravenously administered therapy, and two thirds received less than 2 days of therapy (mean 45.6 +/- 12 hours). There were no statistically significant differences in recurrence rates between the two groups in the 28 days following status asthmaticus. For patients receiving less than or equal to 1 day of therapy, the holding room cost was $526 +/- $226 vs $1439 +/- $339 for hospitalized patients (P less than 0.001). Thus, holding room therapy for childhood status asthmaticus is both medically and economically effective.
Related Concept Videos
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Inhaled Medications
Asthma III: Clinical Manifestations

